|
JP2011087473A
|
|
Biomarkers for predicting therapeutic effect in hyposensitization therapy
|
|
JP2010268688A
|
|
Virus infection system using enterovirus 71 receptor
|
|
JP2010259369A
|
|
Phosphorylated pyruvate carboxylase as marker for age-associated memory disorder
|
|
JP2010241750A
|
|
Benzofuran derivative having anti-hepatitis c virus effect
|
|
JP2010222289A
|
|
Medicine for preventing cell death
|
|
JP2009232836A
|
|
Recombinant vaccinia virus having hepatitis c virus gene
|
|
JP2010006788A
|
|
Antibody conjugate, method for detecting antigen, and method for producing antibody conjugate
|
|
JP2009247219A
|
|
Method for predicting amyotrophic lateral sclerosis by using gene mutation
|
|
JP2008155012A
|
|
Mental condition measuring method, device, and program
|
|
JP2009124990A
|
|
Method for determining antigen
|
|
JP2009109362A
|
|
Method and apparatus for evaluating condition of sample
|
|
JP2008079607A
|
|
Method for evaluating drug sensitivity by analyzing girk channel gene
|
|
JP2009039067A
|
|
Method for judgment of schizophrenia
|
|
JP2008029336A
|
|
Method for screening new drug with gaba or glycine transmission system as target
|
|
JP2007222173A
|
|
Transgenic animal for allergy animal model
|
|
JP2008220174A
|
|
TRANSFORMED CELL COEXPRESSING VARIANT beta-SYNUCLEIN AND alpha-SYNUCLEIN AND TRANSGENIC NON-HUMAN ANIMAL
|
|
JP2008195757A
|
|
Mannose 6-phosphate-polyethylene glycol conjugate
|
|
JP2008141970A
|
|
VARIANT beta-SYNUCLEIN TRANSGENIC NON-HUMAN ANIMAL
|
|
JP2008101924A
|
|
Immunological measuring method for component in urine, and reagent used therein
|
|
JP2008044884A
|
|
Axonal elongation method of nerve cell and method for imparting stress resistance
|
